Variations in erythrocyte antioxidant levels and lipid peroxidation status and in serum lipid profile parameters in relation to blood haemoglobin A1c values in individuals with type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 105, Issue 1, 2014, Pages 58-69

  Annadurai, Thangaraj ^a   Vasanthakumar, Azhagarsamy ^a   Geraldine, Pitchairaj ^a   Thomas, Philip A ^b  

^a BHARATHIDASAN UNIVERSITY   (India)

^b Thomas Diagnostic and Research Centre   (India)

Author keywords

Haemoglobin A1c; Haemolysate; Lipid profile; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

CATALASE; CHOLESTEROL; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; ANTIOXIDANT; LIPID;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETIC PATIENT; ENZYME ACTIVITY; ERYTHROCYTE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; QUANTITATIVE ANALYSIS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; ENZYME ANALYSIS; ERYTHROCYTE ANTIOXIDANT LEVEL; ERYTHROCYTE PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HEMOLYSATE; HUMAN CELL; LIPID BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

HAEMOGLOBIN A1C; HAEMOLYSATE; LIPID PROFILE; OXIDATIVE STRESS; TYPE 2 DIABETES MELLITUS;

ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ERYTHROCYTES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPID PEROXIDATION; LIPIDS;

EID: 84902551428     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.04.018     Document Type: Article

References (60)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl. 1):S62-S69.
2. Folli F., Corradi D., Fanti P., Davalli A., Paez A., Giaccari A., et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev 2011, 7(5):313-324.
3. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17(1):24-38.
4. DCCT The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329(14):977-986.
5. UKPDS Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352(9131):837-853.
6. Selvin E., Steffes M.W., Zhu H., Matsushita K., Wagenknecht L., Pankow J., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010, 362(9):800-811.
7. Mullarkey C.J., Edelstein D., Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 1990, 173(3):932-939.
8. Wolff S.P., Dean R.T. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 1987, 245(1):243-250.
9. McLennan S.V., Heffernan S., Wright L., Rae C., Fisher E., Yue D.K., et al. Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991, 40(3):344-348.
10. Williamson J.R., Chang K., Frangos M., Hasan K.S., Ido Y., Kawamura T., et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993, 42(6):801-813.
11. Obrosova I., Cao X., Greene D.A., Stevens M.J. Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-alpha-lipoic acid. Diabetologia 1998, 41(12):1442-1450.
12. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40(4):405-412.
13. Godin D., Wohaieb S., Garnett M., Goumeniouk A.D. Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem 1988, 84(2):223-231.
14. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 2000, 49(2 Suppl. 1):27-29.
15. Gadi R., Samaha F.F. Dyslipidemia in type 2 diabetes mellitus. Curr Diab Rep 2007, 7(3):228-234.
16. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010, 107(9):1058-1070.
17. Khan S.R., Ayub N., Nawab S., Shamsi T.S. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus. J Coll Physicians Surg Pak 2008, 18(5):270-273.
18. Dodge J.T., Mitchell C., Hanahan D.J. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 1963, 100:119-130.
19. 2+. Biochem Biophys Res Commun 1980, 92(2):631-637.
20. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
21. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974, 47(3):469-474.
22. Sinha A.K. Colorimetric assay of catalase. Anal Biochem 1972, 47(2):389-394.
23. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973, 179(4073):588-590.
24. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979, 582(1):67-78.
25. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95(2):351-358.
26. Preacher K.J. Calculation for the chi-square test: an interactive calculation tool for chi-square tests of goodness of fit and independence [Computer software] 2001, available in http://www.quantpsy.org/chisq/chisq.html.
27. Weber J.C., Lamb D.R. Statistics and Research in Physical Education 1970, CV Mosby Co., St. Louis, 222 pp.
28. Mason R.O., Lind D.A., Marchal W.G. Statistics: an introduction 1983, Harcourt Brace Jovanovich, Inc., New York.
29. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414(6865):813-820.
30. Jokl R., Colwell J.A. Arterial thrombosis and atherosclerosis in diabetes. Diabetes Metab Rev 1997, 5:1-15.
31. Taskinen M.R. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003, 46(6):733-749.
32. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404(6779):787-790.
33. Rosen P., Nawroth P.P., King G., Moller W., Tritschler H.J., Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001, 17(3):189-212.
34. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999, 48(1):1-9.
35. Sundaram R.K., Bhaskar A., Vijayalingam S., Viswanathan M., Mohan R., Shanmugasundaram K.R. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 1996, 90(4):255-260.
36. Bhatia S., Shukla R., Venkata Madhu S., Kaur Gambhir J., Madhava Prabhu K. Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 2003, 36(7):557-562.
37. McCord J.M. Superoxide dismutase 1979, Alan R. Liss Inc., New York. M. Tattazzi, J.G. Scandalios, G.S. Whitt (Eds.).
38. Chance B., Greenstein D.S., Roughton F.J.W. The mechanism of catalase action. I. Steady-state analysis. Arch Biochem Biophys 1952, 37(2):301-321.
39. Yan H., Harding J.J. Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase. Biochem J 1997, 328:599-605.
40. Abou-Seif M.A., Youssef A.A. Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 2004, 346(2):161-170.
41. Arai K., Maguchi S., Fujii S., Ishibashi H., Oikawa K., Taniguchi N. Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites. J Biol Chem 1987, 262(35):16969-16972.
42. Fajans S.S. Diabetes mellitus, definition, classification, tests. Endocrinology 1995, 1411-1422. Saunders Co., Philadelphia. 3rd ed. L. Degroat (Ed.).
43. Halliwell B., Gutteridge J.M., Cross C.E. Free radicals, antioxidants, and human disease: where are we now?. J Lab Clin Med 1992, 119(6):598-620.
44. Szymonik-Lesiuk S., Czechowska G., Stryjecka-Zimmer M., Slomka M., Madro A., Celinski K., et al. Catalase, superoxide dismutase, and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication. J Hepatobiliary Pancreat Surg 2003, 10(4):309-315.
45. Condell R.A., Tappel A.L. Evidence for suitability of glutathione peroxidase as a protective enzyme: studies of oxidative damage, renaturation, and proteolysis. Arch Biochem Biophys 1983, 223(2):407-416.
46. Grzelak A., Soszynski M., Bartosz G. Inactivation of antioxidant enzymes by peroxynitrite. Scand J Clin Lab Invest 2000, 60(4):253-258.
47. Blum J., Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 1985, 240(2):500-508.
48. Bannai S., Tateishi N. Role of membrane transport in metabolism and function of glutathione in mammals. J Membr Biol 1986, 89(1):1-8.
49. Yoshida K., Hirokawa J., Tagami S., Kawakami Y., Urata Y., Kondo T. Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 1995, 38(2):201-210.
50. Lee S.R., Kim J.R., Kwon K.S., Yoon H.W., Levine R.L., Ginsburg A., et al. Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J Biol Chem 1999, 274(8):4722-4734.
51. Halliwell B. Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?. Cardiovasc Res 2000, 47(3):410-418.
52. Altomare E., Vendemiale G., Chicco D., Procacci V., Cirelli F. Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabete Metab 1992, 18:264-271.
53. Krauss R.M. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 2004, 27(6):1496-1504.
54. Howard B.V. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987, 28(6):613-628.
55. Taskinen M.R., Kahri J., Koivisto V., Shepherd J., Packard C.J. Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992, 35(4):347-356.
56. Goldberg I.J. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996, 37(4):693-707.
57. Nacitarhan S., Ozben T., Tuncer N. Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidemia. Free Radic Biol Med 1995, 19(6):893-896.
58. Braga F., Dolci A., Mosca A., Panteghini M. Biological variability of glycated hemoglobin. Clin Chim Acta 2010, 411(21-22):1606-1610.
59. Rohlfing C., Wiedmeyer H.M., Little R., Grotz V.L., Tennill A., England J., et al. Biological variation of glycohemoglobin. Clin Chem 2002, 48(7):1116-1118.
60. Altman D.G., Bland J.M. Standard deviations and standard errors. BMJ 2005, 331(7521):903.